Experiment 636892
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | INTRAGASTRIC |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | PIERRE,S: JAMME,I: DROY-LEFAIX,MT: NOUVELOT,A: MAIXENT,JM:. (1999). GINKGO BILOBA EXTRACT (EGB 761) PROTECTS NA,K-ATPASE ACTIVITY DURING CEREBRAL ISCHEMIA IN MICE.. 10(1) |
| Amount utilized | |
| Compound isolated | |
| Disease | EGB 761 (100 MG/KG) WAS ADMINISTERED DAILY TO HALF OF THE ANIMALS FOR 10 DAYS BEFORE ISCHEMIA. ISCHEMIA SIGNIFICANTLY REDUCED NA,K-ATPASE ACTIVITY BY ABOUT 40% AND INCREASED MALONDIALDEHYDE CONTENT; EGB 761 PRETREATMENT ABOLISHED THESE EFFECTS. A COMMERCIAL PRODUCT, EGB-761, WAS USED. |
| Dose amount | 100.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | MOUSE |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ETOH(100%)EXT |
| Gender | MALE |